Harwood Feffer LLP (
) is investigating potential claims against the board of directors of Animal Health International, Inc. ("Animal Health" or the "Company") (NASDAQ: AHII - News) concerning the Company’s agreement to merge with Lextron, Inc. (“Lextron”) in a transaction valued at approximately $251 million.
On or about March 14, 2011, Animal Health and Lextron announced that they had entered into a definitive merger agreement with support from investment funds from Leonard Green & Partners, LP, pursuant to which Lextron would acquire all the outstanding shares of common stock of Animal Health for $4.26 per share plus the repayment of debt. Investment funds affiliated with Charlesbank Capital Partners, and Jim Robison, Animal Health’s Chairman, President, and CEO, who together own approximately 33% of Animal Health’s outstanding common stock, have agreed to vote in favor of the transaction. Our investigation concerns whether the board of directors is undertaking a fair process to obtain fair consideration for all shareholders of Animal Health. The median target price, according to Yahoo Finance, is $4.50 per share.
If you own shares of Animal Health and would like to learn more about these claims or if you wish to discuss this matter and have any questions or information concerning this announcement, please contact Robert I. Harwood, Esq. at
or Daniella Quitt, Esq. at
. You may also call them at (877) 935-7400. For more information about class actions, or to sign up online, please visit our website:
Harwood Feffer LLP is a national shareholder litigation firm. Harwood Feffer LLP is devoted to protecting the interests of individual and institutional investors in shareholder actions in state and federal courts nationwide.
Attorney Advertising. © 2011 Harwood Feffer LLP. The law firm responsible for this advertisement is Harwood Feffer LLP (
Prior results do not guarantee or predict a similar outcome with respect to any future matter.